Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes

Aims/hypothesisIncreased expression and activity of the lipogenic pathways in adipose tissue may contribute to the development of obesity. As a central enzyme in lipogenesis, the gene encoding fatty acid synthase (FASN) was identified as a candidate gene for determining body fat. In the present study we tested the hypothesis that increased FASN expression links metabolic alterations of excess energy intake, including hyperinsulinaemia, dyslipidaemia and altered adipokine profile to increased body fat mass.Subjects and methodsIn paired samples of visceral and subcutaneous adipose tissue from 196 participants (lean or obese), we investigated whether FASN mRNA expression (assessed by PCR) in adipose tissue is increased in obesity and related to visceral fat accumulation, measures of insulin sensitivity (euglycaemic–hyperinsulinaemic clamp) and glucose metabolism.ResultsFASN mRNA expression was increased by 1.7-fold in visceral vs subcutaneous fat. Visceral adipose tissue FASN expression was correlated with FASN protein levels, subcutaneous FASN expression, visceral fat area, fasting plasma insulin, serum concentrations of IL-6, leptin and retinol-binding protein 4 (RBP4), and inversely with measures of insulin sensitivity, independently of age, sex and BMI. Moreover, we found significant correlations between FASN expression and markers of renal function, including serum creatinine and urinary albumin excretion.Conclusions/interpretationIncreased FASN gene expression in adipose tissue is linked to visceral fat accumulation, impaired insulin sensitivity, increased circulating fasting insulin, IL-6, leptin and RBP4, suggesting an important role of lipogenic pathways in the causal relationship between consequences of excess energy intake and the development of obesity and type 2 diabetes.

[1]  D. Wang,et al.  Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. , 1998, Annual review of nutrition.

[2]  C. Kahn,et al.  Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. , 2002, Developmental cell.

[3]  B. H. Jones,et al.  Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. , 1997, Endocrinology.

[4]  C. Mobbs,et al.  Block the FAS, lose the fat , 2002, Nature Medicine.

[5]  C. Bogardus,et al.  A novel missense substitution (Val1483Ile) in the fatty acid synthase gene (FAS) is associated with percentage of body fat and substrate oxidation rates in nondiabetic Pima Indians. , 2004, Diabetes.

[6]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[7]  M. Douaire,et al.  Association of fatty acid synthase gene and malic enzyme gene polymorphisms with fatness in turkeys. , 1999, Poultry science.

[8]  Nimesh Mody,et al.  Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.

[9]  R. Paschke,et al.  Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes , 2002, Diabetologia.

[10]  C. Semenkovich,et al.  Regulation of fatty acid synthase (FAS). , 1997, Progress in lipid research.

[11]  Jaewon Oh.  Retinol-binding protein 4 and insulin resistance. , 2006, The New England journal of medicine.

[12]  J. Świerczyński,et al.  Comparative study of the lipogenic potential of human and rat adipose tissue. , 2000, Metabolism: clinical and experimental.

[13]  M. Fasshauer,et al.  Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.

[14]  Monica V. Kumar,et al.  Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Ke Chen,et al.  Adipocyte-selective Reduction of the Leptin Receptors Induced by Antisense RNA Leads to Increased Adiposity, Dyslipidemia, and Insulin Resistance* , 2003, Journal of Biological Chemistry.

[16]  D. Chinkes,et al.  Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. , 1996, The Journal of clinical investigation.

[17]  Monica V. Kumar,et al.  Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  V. Large,et al.  Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue Published, JLR Papers in Press, August 1, 2003. DOI 10.1194/jlr.M300235-JLR200 , 2003, Journal of Lipid Research.

[19]  M. Leuze,et al.  The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue. , 2004, The Journal of nutrition.

[20]  M. Beylot,et al.  Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. , 2002, American journal of physiology. Endocrinology and metabolism.

[21]  P. Björntorp,et al.  Uptake of glucose carbon in muscle glycogen and adipose tissue triglycerides in vivo in humans. , 1992, The American journal of physiology.

[22]  J. Świerczyński,et al.  Leptin decreases lipogenic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats. , 2005, Metabolism: clinical and experimental.

[23]  C. Townsend,et al.  Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. , 2000, Science.

[24]  B. Rutkowski,et al.  Upregulation of lipogenic enzymes genes expression in white adipose tissue of rats with chronic renal failure is associated with higher level of sterol regulatory element binding protein-1. , 2004, Metabolism: clinical and experimental.

[25]  C. Semenkovich,et al.  Human fatty acid synthase mRNA: tissue distribution, genetic mapping, and kinetics of decay after glucose deprivation. , 1995, Journal of lipid research.

[26]  B. Rutkowski,et al.  Upregulation of fatty acid synthase gene expression in experimental chronic renal failure. , 2002, Metabolism: clinical and experimental.

[27]  A. Goodridge,et al.  Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. , 1995, Physiological reviews.

[28]  C. Kahn,et al.  Intrinsic Heterogeneity in Adipose Tissue of Fat-specific Insulin Receptor Knock-out Mice Is Associated with Differences in Patterns of Gene Expression* , 2004, Journal of Biological Chemistry.

[29]  J. Buyse,et al.  Potential role of leptin in increase of fatty acid synthase gene expression in chicken liver. , 2005, Domestic animal endocrinology.

[30]  U. Smith,et al.  Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. , 2006, The New England journal of medicine.

[31]  L. Arckens,et al.  FAS inhibitor cerulenin reduces food intake and melanocortin receptor gene expression without modulating the other (an)orexigenic neuropeptides in chickens. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[32]  M. Stumvoll,et al.  Sex-specific effect of the Val1483Ile polymorphism in the fatty acid synthase gene (FAS) on body mass index and lipid profile in Caucasian children , 2007, International Journal of Obesity.